Annual four-day conference in Amsterdam convening healthcare executives, providers, payers, pharma leaders, investors, and digital health innovators to advance healthcare innovation, digital transformation, and AI adoption across European and global health systems.
HLTH Europe is a four-day annual B2B conference held in Amsterdam that brings together senior decision-makers from across the healthcare sector, including providers, payers, pharma companies, health technology firms, investors, and government policy representatives. The event combines a curated programme of panels and presentations with structured networking formats designed to accelerate connections between healthcare incumbents and innovators. It operates as the European counterpart to HLTH's US flagship event, with programming adapted to the European health landscape.
HLTH Europe centres on the intersection of healthcare innovation, digital health adoption, and systemic transformation across European health markets. The programme examines AI applications in clinical and operational settings, the evolving roles of payers and providers, pharmaceutical innovation, health IT infrastructure, and policy frameworks shaping how care is delivered and funded. A dedicated imaging and radiology track, HLTH.rad, broadens the programme beyond digital health to include diagnostic specialisms. The event is positioned as a forum where strategic decisions about healthcare technology procurement, investment, and collaboration can be initiated through both formal programming and facilitated networking.
Speaker information beyond these three names is not publicly disclosed as of verification. The organiser describes the programme as featuring senior European healthcare leaders drawn from providers, payers, and government.
HLTH Europe emphasises curated access and structured connectivity as core components of the event format, not just a supplementary feature. The Market Connect Programme applies an application or qualification layer to matchmaking, and several attendance categories, including startup, investor, and speaker passes, are complimentary subject to eligibility review. The HLTH.rad track also extends the programme to include imaging and radiology as a distinct specialism alongside broader digital health content.
The event is positioned as a strategic leadership forum rather than a technology showcase or trade exhibition. Exhibitor figures are not publicly disclosed as of verification, and the programme structure prioritises panels, curated conversations, and facilitated 1:1 meetings. Startup participants attend through an application-based qualification process, which orients their presence toward investor and partner introductions rather than floor demonstrations.
Yes. HLTH Europe is produced by HLTH Inc., the same New York-based organisation that runs HLTH US and ViVE. The European event operates on the same structural model, including the Market Connect Programme format and the complimentary access tiers for qualified participants, adapted for the European market and health system context.
The RAI Amsterdam Convention Centre is located at Europaplein 22, 1078 GZ Amsterdam, Netherlands. It is one of Europe's larger convention and exhibition venues, regularly hosting major international B2B conferences across multiple sectors. Amsterdam's Schiphol Airport provides direct connections to most European capitals and major intercontinental routes, making the city a logistically accessible base for pan-European and international attendees.
HLTH Inc. is a New York-based conference producer and digital content company founded in 2016, with an estimated workforce of 80 to 100 employees. The company focuses specifically on the healthcare sector, operating large-scale forums that bring together health system incumbents, technology companies, investors, and policy stakeholders. Its event portfolio includes HLTH US, HLTH Europe, and ViVE, which is co-produced with CHIME and targets health IT leadership in North America.
HLTH Inc. was acquired by Hyve Group, an independent media and events company owned by private equity firms Providence and Searchlight. This acquisition placed HLTH within a broader international events portfolio while maintaining the HLTH brand identity and event formats. The company's stated focus is on convening healthcare decision-makers through global events, digital content, and structured initiatives rather than general industry exhibitions.
HLTH Europe occupies a distinct position on the European health conference circuit by combining a qualification-based access model with dedicated sector tracks such as HLTH.rad, setting it apart from open-registration digital health gatherings and traditional medical conference formats.
Registration for HLTH Europe 2026 is open. The event operates a complimentary access model across its primary attendance categories, subject to qualification or pre-approval:
Pricing for any paid tiers is not publicly disclosed as of verification. Early bird deadlines are not publicly disclosed as of verification. Registration is available at the official registration page listed in the Resources section below.
HLTH Europe incorporates structured networking as a central programme component rather than a peripheral feature. The Market Connect Programme offers advance-scheduled 1:1 meetings between qualified attendees, enabling participants to arrange introductions before the event opens. Scheduling capabilities are supported through the HLTH Europe app, the official digital companion for the event; the underlying platform provider (Hopin, Swapcard, Brella, or equivalent) is not publicly disclosed as of verification. Affinity meetups and networking receptions provide additional touchpoints across the four days. On-demand replay access is not offered.
HLTH Europe has an open call for speakers for its 2026 edition. Applications can be submitted via the official speakers page. The submission deadline is not publicly disclosed as of verification. Topics of interest include healthcare innovation, digital health, radiology and imaging, provider perspectives, payer perspectives, and pharmaceutical innovations. Speaker participation is complimentary for accepted applicants.
Speaker application URL: https://hlth.com/events/europe/speakers/
Attendance across the main categories (delegate, startup, investor, speaker, press) is offered on a complimentary basis, but access is not unconditional. Startup and investor categories require completion of a qualification or application process. Media access requires pre-approval. Delegate eligibility criteria are not publicly disclosed as of verification. Applicants should expect a review period between submission and confirmation.
Yes. The event is held in Amsterdam, which has strong international transport connectivity through Schiphol Airport. The programme language is English. The event regularly attracts participants from beyond the EMEA region, and the HLTH brand has an established presence in the US market through its domestic events.
Official accommodation and travel guidance is not publicly disclosed as of verification. Attendees should refer to the official event website for any partner hotel blocks or venue logistics information published closer to the June 2026 dates.
| Official website | https://hlth.com/events/europe/ |
| Register | https://europe.hlth.com/register |
| https://www.linkedin.com/company/hlthevent | |
| Speaker application | https://hlth.com/events/europe/speakers/ |
| Organiser website | https://hlth.com |